Location History:
- Doylestown, PA (US) (2004 - 2022)
- Spring House, PA (US) (2023)
Company Filing History:
12 out of 2,078 
9 out of 3,684 
4 out of 363 
Years Active: 2004-2023
Title: Innovations of Stuart Emanuel: A Pioneer in STING Modulation
Introduction
Stuart Emanuel, based in Doylestown, PA, is an accomplished inventor with a remarkable portfolio of 29 patents. His innovative contributions primarily focus on the modulation of STING (Stimulator of Interferon Genes) pathways, which have significant implications for treating various diseases and disorders.
Latest Patents
Among his most recent patents, Stuart has developed cyclic dinucleotides as STING agonists. These compounds, compositions, and methods are aimed at treating diseases, syndromes, or disorders impacted by STING modulation. The inventive compounds are represented by specific formulas that detail the arrangement of various chemical components.
Career Highlights
Stuart has made significant strides in the pharmaceutical industry, working with leading companies such as Janssen Pharmaceutica and Bristol-Myers Squibb Company. His expertise in drug discovery and development has allowed him to contribute substantially to advancements in therapeutic options for numerous health challenges.
Collaborations
Throughout his career, Stuart has collaborated with prominent professionals in the field, including coworkers Peter J. Connolly and Steven A. Middleton. These collaborations are indicative of a strong network that supports innovation and progress in medical research.
Conclusion
Stuart Emanuel stands out as an influential inventor in the realm of STING modulation. His 29 patents reflect a commitment to innovation and a dedication to addressing pressing medical issues. With ongoing research and collaboration, his work continues to pave the way for potential breakthroughs in therapeutic solutions.